Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Feiyue Feng"'
Autor:
Ziqiang Chen, Xiaobing Wang, Zelin Jin, Bosen Li, Dongxian Jiang, Yanqiu Wang, Mengping Jiang, Dandan Zhang, Pei Yuan, Yahui Zhao, Feiyue Feng, Yicheng Lin, Liping Jiang, Chenxi Wang, Weida Meng, Wenjing Ye, Jie Wang, Wenqing Qiu, Houbao Liu, Dan Huang, Yingyong Hou, Xuefei Wang, Yuchen Jiao, Jianming Ying, Zhihua Liu, Yun Liu
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Tertiary lymphoid structures (TLSs) have been associated with favorable immunotherapy responses and prognosis in various cancers. Despite their significance, their quantification using multiplex immunohistochemistry (mIHC) staining of T and
Externí odkaz:
https://doaj.org/article/a91d33dd21914b1dba5d286047bfe39c
Autor:
Jiaxi Xu, Hui Zeng, Guochao Zhang, Renda Li, Zhenlong Yuan, Jingyu Ren, Yufei Huang, Fangzhou Ren, Hao Zhang, Kailun Fei, Feiyue Feng, Fengwei Tan
Publikováno v:
Thoracic Cancer, Vol 14, Iss 31, Pp 3108-3118 (2023)
Abstract Background This study aimed to establish a nomogram for predicting risk of recurrence and provide a model for decision‐making between lobectomy and sublobar resection in patients with stage IA lung adenocarcinoma. Methods Patients diagnose
Externí odkaz:
https://doaj.org/article/98c6070734d4449aaf61b067df38f264
Autor:
Fenglong Bie, Zhijie Wang, Yulong Li, Wei Guo, Yuanyuan Hong, Tiancheng Han, Fang Lv, Shunli Yang, Suxing Li, Xi Li, Peiyao Nie, Shun Xu, Ruochuan Zang, Moyan Zhang, Peng Song, Feiyue Feng, Jianchun Duan, Guangyu Bai, Yuan Li, Qilin Huai, Bolun Zhou, Yu S. Huang, Weizhi Chen, Fengwei Tan, Shugeng Gao
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
Abstract Multimodal epigenetic characterization of cell-free DNA (cfDNA) could improve the performance of blood-based early cancer detection. However, integrative profiling of cfDNA methylome and fragmentome has been technologically challenging. Here
Externí odkaz:
https://doaj.org/article/1dac2947a89c4d6f857ab60c3f8e4c7c
Autor:
Zheng Wu, Fengwei Tan, Yaozeng Xie, Wei Tang, Fei Wang, Yongjie Xu, Wei Cao, Chao Qin, Xuesi Dong, Yadi Zheng, Zilin Luo, Chenran Wang, Liang Zhao, Changfa Xia, Jiang Li, Renda Li, Feiyue Feng, Jibin Li, Jiansong Ren, Jufang Shi, Hong Cui, Sipeng Shen, Ning Wu, Wanqing Chen, Ni Li, Jie He
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 14781-14793 (2023)
Abstract Background The ability of lung cancer screening to manage pulmonary nodules was limited because of the high false‐positive rate in the current mainstream screening method, low‐dose computed tomography (LDCT). We aimed to reduce overdiagn
Externí odkaz:
https://doaj.org/article/e696a53676d5407ea0419855a8b4e09e
Autor:
Dantong Sun, Feiyue Feng, Fei Teng, Tongji Xie, Jinsong Wang, Puyuan Xing, Haili Qian, Junling Li
Publikováno v:
Cell Communication and Signaling, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Introduction Dysregulated ARID1A expression is frequently detected in lung adenocarcinoma (LUAD) and mediates significant changes in cancer behaviors and a poor prognosis. ARID1A deficiency in LUAD enhances proliferation and metastasis, whic
Externí odkaz:
https://doaj.org/article/b44b859bf4da482ab95281c171696e57
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesThis study aimed to identify the computed tomography (CT) features associated with the new International Association for the Study of Lung Cancer (IASLC) three-tiered grading system to improve the preoperative prediction of disease-free sur
Externí odkaz:
https://doaj.org/article/0822458ada494796a2b4109f79caf041
Autor:
Xiao Chang, Junqiang Chen, Wencheng Zhang, Jinsong Yang, Shufei Yu, Wei Deng, Wenjie Ni, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jima Lv, Jun Liang, Zhouguang Hui, Lvhua Wang, Yu Lin, Xiaohui Chen, Qi Xue, Yousheng Mao, Yushun Gao, Dali Wang, Feiyue Feng, Shugeng Gao, Jie He, Zefen Xiao
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: A reliable model is needed to estimate the risk of postoperative recurrence and the benefits of postoperative radiotherapy (PORT) in patients with thoracic esophageal squamous cell cancer (TESCC). Methods: The study retrospectively review
Externí odkaz:
https://doaj.org/article/2b6902b0d3474391877ca0d30c213888
Autor:
Yingxi, Du, Yarui, Ma, Qing, Zhu, Yong, Fu, Yutong, Li, Ying, Zhang, Mo, Li, Feiyue, Feng, Peng, Yuan, Xiaobing, Wang
Publikováno v:
Frontiers of Medicine. 17:119-131
Treating patients with esophageal squamous cell carcinoma (ESCC) is challenging due to the high chemoresistance. Growth differentiation factor 15 (GDF15) is crucial in the development of various types of tumors and negatively related to the prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c105eb9d12825e02eeb0abf9dc37b69b
https://doi.org/10.1007/s11684-022-0949-7
https://doi.org/10.1007/s11684-022-0949-7
Autor:
Fengwei Tan, Nan Bi, Hao Zhang, Renda Li, Zhijie Wang, Jianchun Duan, Feng Jiang, Dongjie Feng, Rongsheng Zhang, Junjun Bai, Jianzhong Cao, Naiquan Mao, Kai Liang, Shiquan Yin, Yaxing Shen, Feiyue Feng, Jun Zhao, Yushun Gao, Yousheng Mao, Qi Xue, Shugeng Gao, Jie He
Publikováno v:
Lung Cancer. 170:98-104
The newly released eighth edition of the American Joint Committee on Cancer TNM staging system for lung cancer seeks to improve prognostic accuracy but lacks external validation for small cell lung cancer (SCLC). Moreover, previous studies posed a fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f29edef714dedb86a570cbed7b74e70
https://doi.org/10.1016/j.lungcan.2022.03.011
https://doi.org/10.1016/j.lungcan.2022.03.011
Autor:
Fenglong Bie, Zhijie Wang, Yulong Li, Yuanyuan Hong, Tiancheng Han, Fang Lv, Shunli Yang, Suxing Li, Xi Li, Peiyao Nie, Ruochuan Zang, Moyan Zhang, Peng Song, Feiyue Feng, Wei Guo, Jianchun Duan, Guangyu Bai, Yuan Li, Qilin Huai, Bolun Zhou, Yu Huang, Weizhi Chen, Fengwei Tan, Shugeng Gao
Plasma cell-free DNA (cfDNA) methylation and fragmentation signatures have been shown to be valid biomarkers for blood-based cancer detection. However, conventional methylation sequencing assays are inapplicable for fragmentomic profiling due to bisu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::874cd62e65280037febb8643a9e2db2f
https://doi.org/10.1101/2022.07.04.498641
https://doi.org/10.1101/2022.07.04.498641
